KARA CLEMMER: Open Payments
NPI 1548749021 · LINCOLNTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,051 in 48 payments from 14 companies in 2025. Trend: 2023 $472 · 2024 $0 · 2025 $1,051
Food & beverage: $1,051
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $169 |
| Verona Pharma, Inc. | 8 | $167 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| Insmed, Inc. | 5 | $113 |
| United Therapeutics Corporation | 4 | $106 |
| Viatris Specialty LLC | 5 | $93 |
| GENZYME CORPORATION | 3 | $76 |
| Grifols USA, LLC | 3 | $62 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| ANI Pharmaceuticals, Inc. | 2 | $37 |
Products named: DUPIXENT, Ohtuvayre, Arikayce, Tyvaso, YUPELRI, TEZSPIRE, Prolastin-C Liquid, FASENRA.
Industry payments across NC — which companies pay providers there.
